Interim safety and efficacy data in XLRS patients validates the use of a novel, laterally spreading capsid for the treatment of retinal disease

ATSN-201 - Atsena Therap

https://eppro02.ativ.me/web/page.php?page=IntHtml&project=ARVO25&id=4238678

Lesley A. Everett4; Aaron Nagiel2,6; Byron L. Lam3; Andreas K. Lauer4; Audina Berrocal3; Nell Gregori3; Shannon Elizabeth Boye5; Sanford L. Boye5; Laura P. Pardon1; Dan Yoon1; Christine Kay7; Kenji Fujita1

Mar 26, 2025